260 related articles for article (PubMed ID: 25938461)
1. MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.
Olasz EB; Seline LN; Schock AM; Duncan NE; Lopez A; Lazar J; Flister MJ; Lu Y; Liu P; Sokumbi O; Harwood CA; Proby CM; Neuburg M; Lazarova Z
PLoS One; 2015; 10(5):e0125412. PubMed ID: 25938461
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.
Xu N; Zhang L; Meisgen F; Harada M; Heilborn J; Homey B; Grandér D; Ståhle M; Sonkoly E; Pivarcsi A
J Biol Chem; 2012 Aug; 287(35):29899-908. PubMed ID: 22782903
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1.
Lin CW; Chang YL; Chang YC; Lin JC; Chen CC; Pan SH; Wu CT; Chen HY; Yang SC; Hong TM; Yang PC
Nat Commun; 2013; 4():1877. PubMed ID: 23695671
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC.
Lohcharoenkal W; Harada M; Lovén J; Meisgen F; Landén NX; Zhang L; Lapins J; Mahapatra KD; Shi H; Nissinen L; Kähäri VM; Ståhle M; Sonkoly E; Grandér D; Arsenian-Henriksson M; Pivarcsi A
J Invest Dermatol; 2016 Dec; 136(12):2485-2494. PubMed ID: 27452220
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells.
Wang A; Landén NX; Meisgen F; Lohcharoenkal W; Ståhle M; Sonkoly E; Pivarcsi A
PLoS One; 2014; 9(7):e103206. PubMed ID: 25068518
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
[TBL] [Abstract][Full Text] [Related]
7. microRNA-214 Prevents Traits of Cutaneous Squamous Cell Carcinoma via VEGFA and Bcl-2.
Ma X; Wu D; Zhang X; Shao X; Hu G
Technol Cancer Res Treat; 2020; 19():1533033820980098. PubMed ID: 33280526
[TBL] [Abstract][Full Text] [Related]
8. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
9. miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.
Zhou J; Zhang Y; Han Z; Dong Z; Cao T; Wei A; Guo P; Meng Q
Cell Cycle; 2019 Feb; 18(3):333-345. PubMed ID: 30646812
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
11. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
[TBL] [Abstract][Full Text] [Related]
13. MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1.
Lohcharoenkal W; Li C; Das Mahapatra K; Lapins J; Homey B; Sonkoly E; Pivarcsi A
J Invest Dermatol; 2021 Aug; 141(8):1922-1931. PubMed ID: 33766507
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
15. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Chen IP; Bender M; Spassova I; Henning S; Kubat L; Fan K; Degenhardt S; Mhamdi-Ghodbani M; Sriram A; Volkmer B; Boukamp P; Becker JC; Greinert R
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3215-3231. PubMed ID: 32865618
[TBL] [Abstract][Full Text] [Related]
16. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Xu Z; Wang T
Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
[TBL] [Abstract][Full Text] [Related]
17. Role of miR-148a in cutaneous squamous cell carcinoma by repression of MAPK pathway.
Luo Q; Li W; Zhao T; Tian X; Liu Y; Zhang X
Arch Biochem Biophys; 2015 Oct; 583():47-54. PubMed ID: 26253263
[TBL] [Abstract][Full Text] [Related]
18. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
Wang J; Li C; Xu L; Yang C; Zhang X
Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-346 functions as an oncogene in cutaneous squamous cell carcinoma.
Chen B; Pan W; Lin X; Hu Z; Jin Y; Chen H; Ma G; Qiu Y; Chang L; Hua C; Zou Y; Gao Y; Ying H; Lv D
Tumour Biol; 2016 Feb; 37(2):2765-71. PubMed ID: 26408183
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
